824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis

Podobne zapisy

• 1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
  od: Patterson, Thomas, i wsp.
  Wydane: (2014)
• 825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections
  od: Raad, Issam, i wsp.
  Wydane: (2014)
• Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
  od: Perfect, John R., i wsp.
  Wydane: (2018)
• Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
  od: Thompson, George R., i wsp.
  Wydane: (2016)
• 1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
  od: Kontoyiannis, Dimitrios, i wsp.
  Wydane: (2014)